News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
855,795 Results
Type
Article (87075)
Company Profile (704)
Press Release (768001)
Multimedia
Podcasts (156)
Webinars (21)
Section
Business (232916)
Career Advice (4135)
Deals (39772)
Drug Delivery (131)
Drug Development (91153)
Employer Resources (200)
FDA (18219)
Job Trends (17377)
News (397043)
Policy (39862)
Tag
Academia (3002)
Academic (2)
Accelerated approval (15)
Adcomms (33)
Allergies (111)
Alliances (56978)
ALS (125)
Alzheimer's disease (1623)
Antibody-drug conjugate (ADC) (195)
Approvals (18197)
Artificial intelligence (422)
Autoimmune disease (39)
Automation (22)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (141)
Biotechnology (482)
Bladder cancer (110)
Brain cancer (44)
Breast cancer (416)
Cancer (3310)
Cardiovascular disease (265)
Career advice (3544)
Career pathing (34)
CAR-T (219)
CDC (43)
Cell therapy (605)
Cervical cancer (26)
Clinical research (74631)
Collaboration (1193)
Company closure (4)
Compensation (803)
Complete response letters (42)
COVID-19 (2923)
CRISPR (71)
C-suite (427)
Cystic fibrosis (126)
Data (3387)
Decentralized trials (2)
Denatured (56)
Depression (86)
Diabetes (392)
Diagnostics (7017)
Digital health (26)
Diversity (10)
Diversity, equity & inclusion (49)
Drug discovery (196)
Drug pricing (163)
Drug shortages (36)
Duchenne muscular dystrophy (171)
Earnings (98532)
Editorial (51)
Employer branding (25)
Employer resources (169)
Events (131772)
Executive appointments (935)
FDA (20298)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (11)
Funding (1066)
Gene editing (154)
Generative AI (42)
Gene therapy (477)
GLP-1 (971)
Government (5311)
Grass and pollen (7)
Guidances (325)
Healthcare (20921)
HIV (47)
Huntington's disease (32)
IgA nephropathy (48)
Immunology and inflammation (199)
Immuno-oncology (17)
Indications (43)
Infectious disease (3131)
Inflammatory bowel disease (171)
Inflation Reduction Act (13)
Influenza (81)
Intellectual property (143)
Interviews (813)
IPO (17911)
IRA (58)
Job creations (5194)
Job search strategy (2863)
Kidney cancer (15)
Labor market (64)
Layoffs (612)
Leadership (27)
Legal (10141)
Liver cancer (87)
Longevity (12)
Lung cancer (460)
Lymphoma (234)
Machine learning (16)
Management (65)
Manufacturing (503)
MASH (111)
Medical device (14785)
Medtech (14797)
Mergers & acquisitions (22640)
Metabolic disorders (1011)
Multiple sclerosis (107)
NASH (23)
Neurodegenerative disease (166)
Neuropsychiatric disorders (48)
Neuroscience (2447)
NextGen: Class of 2025 (7687)
Non-profit (5093)
Now hiring (52)
Obesity (509)
Opinion (298)
Ovarian cancer (109)
Pain (137)
Pancreatic cancer (137)
Parkinson's disease (209)
Partnered (26)
Patents (355)
Patient recruitment (215)
Peanut (55)
People (65887)
Pharmaceutical (143)
Pharmacy benefit managers (25)
Phase I (23018)
Phase II (32394)
Phase III (24405)
Pipeline (2266)
Policy (265)
Postmarket research (3554)
Preclinical (10399)
Press Release (72)
Prostate cancer (161)
Psychedelics (46)
Radiopharmaceuticals (279)
Rare diseases (558)
Real estate (7404)
Recruiting (76)
Regulatory (27442)
Reports (64)
Research institute (2667)
Resumes & cover letters (650)
Rett syndrome (10)
RNA editing (13)
RSV (62)
Schizophrenia (112)
Series A (177)
Series B (128)
Service/supplier (30)
Sickle cell disease (71)
Special edition (23)
Spinal muscular atrophy (168)
Sponsored (38)
Startups (4310)
State (2)
Stomach cancer (17)
Supply chain (86)
Tariffs (77)
The Weekly (98)
Vaccines (965)
Venture capital (62)
Weight loss (350)
Women's health (53)
Worklife (20)
Date
Today (104)
Last 7 days (620)
Last 30 days (2688)
Last 365 days (33935)
2025 (21334)
2024 (38139)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1278)
Alabama (73)
Alaska (7)
Arizona (288)
Arkansas (14)
Asia (50656)
Australia (8899)
California (8407)
Canada (2567)
China (769)
Colorado (359)
Connecticut (377)
Delaware (227)
Europe (116316)
Florida (1262)
Georgia (286)
Hawaii (3)
Idaho (67)
Illinois (768)
India (37)
Indiana (408)
Iowa (19)
Japan (251)
Kansas (119)
Kentucky (34)
Louisiana (20)
Maine (75)
Maryland (1170)
Massachusetts (6387)
Michigan (286)
Minnesota (520)
Mississippi (4)
Missouri (109)
Montana (32)
Nebraska (26)
Nevada (93)
New Hampshire (75)
New Jersey (2333)
New Mexico (31)
New York (2314)
North Carolina (1304)
North Dakota (10)
Northern California (3695)
Ohio (268)
Oklahoma (17)
Oregon (48)
Pennsylvania (1790)
Puerto Rico (18)
Rhode Island (42)
South America (1654)
South Carolina (40)
South Dakota (1)
Southern California (3157)
Tennessee (136)
Texas (1311)
United States (31491)
Utah (250)
Virginia (229)
Washington D.C. (80)
Washington State (726)
West Virginia (4)
Wisconsin (89)
There are 855,795 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Immuno-oncology
Genentech Walks Away From $2B Partnership With Adaptive Biotechnologies
Adaptive and Genentech first partnered in 2018 to advance T cell receptor-based therapies for cancer.
August 19, 2025
·
1 min read
·
Tristan Manalac
Collaboration
VantAI Links With Halda in Potential $1B+ Proteomics Pact
VantAI will use its machine learning capabilities to identify novel target-effector pairs that Halda can use in designing its bifunctional small-molecule drugs.
August 19, 2025
·
2 min read
·
Tristan Manalac
Manufacturing
Oral Wegovy’s Pending Approval Puts Spotlight on Viability of High-Dose Peptides
While the 10-fold increase in dose over injectable Wegovy has raised questions about the launch, Novo Nordisk has assured investors it has the manufacturing capacity to roll out oral semaglutide without restrictions on supply.
August 19, 2025
·
5 min read
·
Nick Paul Taylor
Press Releases
VASTHERA Receives U.S. FDA Clearance to initiate Phase 1 Clinical Trial of Pulmonary Arterial Hypertension Drug Candidate, VTB-10
August 19, 2025
·
1 min read
Press Releases
Insulet to Participate in Upcoming September 2025 Investor Conferences
August 19, 2025
·
1 min read
Press Releases
Selonterra announces grant of United States patent on original discoveries in Alzheimer’s disease
August 19, 2025
·
1 min read
Press Releases
Greenwich LifeSciences Announces Plan to Build Out Internal Clinical Operations Team
August 19, 2025
·
6 min read
Press Releases
Zymeworks Announces Participation in Upcoming September 2025 Investor Conferences
August 19, 2025
·
2 min read
Press Releases
ITM to Present New Subgroup Analysis Data from the COMPETE Trial at ESMO 2025 and Host an Educational Event for Healthcare Professionals
August 19, 2025
·
3 min read
Press Releases
AlzeCure Pharma Livestreams Event about The Pain Project ACD440 and The Opportunities Within Orphan Drugs
August 19, 2025
·
5 min read
1 of 85,580
Next
